Related Experiment Videos
Death ligands and bisindolylmaleimide: a killer combination
1Hamon Center for Therapeutic Oncology Research and Division of Hematology-Oncology, University of Texas Southwestern Medical Center, Dallas, Texas 75390-8593, USA. preet.chaudhary@utsouthwestern.edu.
Cancer Biology & Therapy
|July 25, 2003
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Unique challenges to diagnosing sweet syndrome following induction chemotherapy for relapsed Acute Myeloid Leukemia (AML): A case and brief-review.
Respiratory medicine case reports·2023
A novel thermostable beetle luciferase based cytotoxicity assay.
Scientific reports·2021
The molecular mechanisms of platelets in tumor invasion and metastasis: a controversial role.
Cancer biology & therapy·2026
Molecular interplay of insulin resistance and cancer: advances in monoclonal antibody therapeutics.
Cancer biology & therapy·2026
DNA polymerase theta (Polθ): a novel candidate for targeted cancer therapy.
Cancer biology & therapy·2026
Targeting molecular and genetic pathways driving tumorigenesis for precision therapy in colorectal cancer.
Cancer biology & therapy·2026
Bis-(di-4-phenyl-benzylaminethiocarbonyl)disulfide sensitizes ABCC2/ALDH3A1 overexpressing NSCLC cells to cisplatin.
Cancer biology & therapy·2026
Inclusive designs that allow the inclusion of a broader population in randomized controlled trials: An evaluation of randomization ratio and analysis strategy.
Statistical methods in medical research·2026
A Novel tRNA Half mt-5'-tiRNA-Tyr Promotes Colorectal Cancer Proliferation via Inducing HARS2 Succinylation.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Clinically Relevant Outcomes With Romiplostim in Patients With Solid Tumors and Persistent Chemotherapy Induced Thrombocytopenia.
American journal of hematology·2026